Trial Profile
A Comparative Bioavailability Study of UT-15C SR (Treprostinil Diethanolamine, Sustained Release) Oral Tablets and UT-15C (Treprostinil Diethanolamine) Administered as an Oral Solution in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Aug 2014
Price :
$35
*
At a glance
- Drugs Treprostinil (Primary)
- Indications Peripheral ischaemia; Pulmonary arterial hypertension
- Focus Pharmacokinetics
- Sponsors United Therapeutics Corporation
- 08 Aug 2014 New trial record
- 12 Oct 2010